Real-time enrollment status for this irritability associated with autism spectrum disorder clinical trial
Current Status
Recruiting
Checked: November 12, 2026 at 9:55 AM UTC
| NCT Number | NCT07284745 |
| Recruiting Status | Recruiting |
| Condition | Irritability Associated With Autism Spectrum Disorder |
| Phase | PHASE3 |
| Target Enrollment | 176 participants |
| Active Locations | 31 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | November 10, 2026 (2 days ago) |
As of November 12, 2026: Clinical trial NCT07284745 is currently recruiting participants. This phase3 study for irritability associated with autism spectrum disorder is actively seeking new participants at 31 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07284745 is actively recruiting participants as of November 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 31 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07284745 was last updated 2 days ago (November 10, 2026). HelloStudys verifies this status automatically.